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Abstract Three populations of neurons expressing the
vesicular glutamate transporter 2 (Vglut2) were recently
described in the A10 area of the mouse midbrain, of which
two populations were shown to express the gene encoding,
the rate-limiting enzyme for catecholamine synthesis,
tyrosine hydroxylase (TH).One of these populations (‘‘TH–
Vglut2 Class1’’) also expressed the dopamine transporter
(DAT) gene while one did not (‘‘TH–Vglut2 Class2’’), and
the remaining population did not express TH at all
(‘‘Vglut2-only’’). TH is known to be expressed by a pro-
moter which shows two phases of activation, a transient
one early during embryonal development, and a later one
which gives rise to stable endogenous expression of the TH
gene. The transient phase is, however, not specific to cat-
echolaminergic neurons, a feature taken to advantage here
as it enabled Vglut2 gene targeting within all three A10
populations expressing this gene, thus creating a new
conditional knockout. These knockout mice showed
impairment in spatial memory function. Electrophysiolog-
ical analyses revealed a profound alteration of oscillatory
activity in the CA3 region of the hippocampus. In addition
to identifying a novel role for Vglut2 in hippocampus
function, this study points to the need for improved genetic
tools for targeting of the diversity of subpopulations of the
A10 area.
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Introduction
The A10 area of the ventral midbrain is the home of the
classical dopamine (DA) neurons that are important for
motivation, reward, learning and memory via substantial
projections into limbic and cognitive regions. A10 consists
of the ventral tegmental area (VTA) and three midline
nuclei, known as the interfascicular (IF), rostral linear
(RLi) and caudal linear (CLi) nuclei, respectively (Fields
et al. 2007; Ikemoto 2007). Recent studies have shown that
the medial VTA together with IF and RLi, which collec-
tively often are referred to simply as the VTA, are more
heterogeneous in terms of cell populations than previously
thought (Li et al. 2013). For example, three distinct neu-
ronal populations expressing the vesicular glutamate
transporter 2 (Vglut2, aka Slc17A6) gene, which confers a
glutamatergic phenotype (Fremeau et al. 2004), have been
identified within the VTA of the adult rat and mouse. Of
these three VTA Vglut2-expressing (VTA-VGLUT2) pop-
ulations, one appears to consist of purely glutamatergic
neurons (‘‘Glu-only’’ or ‘‘Vglut2-only’’) that show similar
electrophysiological properties and projections as the
neighbouring DA neurons (Hnasko et al. 2012; Kawano
et al. 2006; Yamaguchi et al. 2007). The other two popu-
lations both express tyrosine hydroxylase (TH), the rate-
limiting enzyme in DA synthesis, along with Vglut2, but
differ with regards to their expression of the dopamine
transporter (DAT) (Li et al. 2013). Thus, the neurons in one
VTA-VGLUT2 population coexpress TH and DAT and
have been named ‘‘TH–Vglut2 Class 1’’ neurons, while the
other population contains neurons that do not express DAT
and are referred to as ‘‘TH–Vglut2 Class 2’’ neurons (Li
et al. 2013). Both of these TH–Vglut2 populations pre-
sumably represent DA neurons that corelease glutamate
[reviewed in (El Mestikawy et al. 2011; Hnasko and
Edwards 2012)]. In addition to the unique property of
expression in DA neurons, Vglut2 is distinct from its sister
molecules Vglut1 and Vglut3 in that Vglut2 is the only
isoform which can be broadly detected already at midg-
estation, including within the developing VTA (Birgner
et al. 2010). The functional role of Vglut2 expression in DA
neurons has been investigated by different laboratories
using the Cre-LoxP-based conditional knockout technique
(Walle´n-Mackenzie et al. 2010) targeting DA neurons via
DAT promoter-driven expression of Cre recombinase.
Briefly summarized, these studies demonstrated that DAT-
Cre-mediated deletion of Vglut2 expression left motivation
and memory parameters intact, while causing altered
responses to sweet food and psychostimulants, thereby
revealing a role for the glutamate-DA cophenotype in
certain aspects of reward processing (Alsio¨ et al. 2011;
Birgner et al. 2010; Fortin et al. 2012; Hnasko et al. 2010).
Spatially, DAT-Cre is to date the most appropriate Cre-
driver for targeting gene expression in DA neurons, but
temporally, Vglut2 expression, detected in the VTA at
embryonic day (E) 11, is more tuned with TH expression
(E11; Zetterstro¨m et al. (1997)) which precedes that of
DAT (E14; Fauchey et al. (2000)) by several days. To
explore the possibility of targeting Vglut2 in DA neurons
already from midgestation, we therefore turned to a pre-
viously validated TH-ires-Cre knock-in mouse (Lindeberg
et al. 2004) known to recapitulate endogenous TH
expression, and we could indeed verify this expected Cre
activity. Somewhat surprisingly, ectopic Cre activity was
also detected in the ‘‘Vglut2-only’’ neurons of the VTA.
Thus, based on the promiscuity of the TH promoter, we
hypothesized that we had a genetic tool at hand which we
could use for targeting neurons within all three VTA-
VGLUT2 populations, i.e. ‘‘Vglut2-only’’, ‘‘TH–Vglut2
Class 1’’ and ‘‘TH–Vglut2 Class 2’’ neurons. Upon verifi-
cation, we used behavioural, electrochemical and electro-




All mice used in the study were housed in the animal
facility at the BMC, Uppsala University, in accordance
with the Swedish regulation guidelines (Animal Welfare
Act SFS 1998:56) and European Union legislation (Con-
vention ETS123 and Directive 2010/63/EU). Ethical
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approval was obtained from the Uppsala Animal Ethical
Committee. The animals were housed by sex in standard
Makrolon cages (59 9 38 9 20 cm) with aspen wood
bedding (Scanbur AB Sollentuna, Sweden) and a wooden
house. The temperature was kept at 21–22 C with a
humidity of 45–55 %. A 12 h light/12 h dark cycle was
used, with lights on at 07.00 h. The animals had ad libitum
access to food (R36, Labfor, Lactamin, Vadstena, Sweden)
and water.
Generation of transgenic mice
The Vglut2f/f;TH-Cre mouse line was produced using the
breeding procedure established for conditional knockout
mice to ensure identical genetic background (Crusio 2004)
by breeding the Th-IRES-Cre (here abbreviated as TH-Cre)
knock-in mouse line (on a C57BL/6 J genetic background)
(Lindeberg et al. 2004) to the Vglut2f/f mouse line (on a
C57BL/6 J-SV129 genetic background) (Walle´n-Macken-
zie et al. 2009) thereby generating cKO (Vglut2f/f;TH-Cre?)
and control (Vglut2f/f;TH-Cre-) mice as littermates which
allows for behavioural phenotyping and comparison
between genotype groups (Wolfer et al. 2002). The gen-
eration of Vglut2f/f;TH-Cre mouse line was described previ-
ously and it was demonstrated that a subset of Vglut2f/f;TH-
CrecKO mice have an itch phenotype at a late adult stage
(Lagerstrom et al. 2010). None of the analyses in the cur-
rent study included adult mice showing an itch phenotype.
The Vglut2f/f mouse line was bred with the TaumGFP
reporter mouse line (Hippenmeyer et al. 2005) to allow
histological and single-cell RT-PCR analyses with selec-
tivity for the TH-Cre-expressing cells, thus producing the
Vglut2f/f;Tau-mGFP mouse, which was subsequently crossed
with the TH-Cre mice to produce Vglut2f/f;TH-Cre;Tau-mGFP
(cKO-Cre-GFP) and Vglut2f/?;TH-Cre;Tau-mGFP littermate
controls (Ctrl-Cre-GFP). The TaumGFP Cre-reporter mouse
allows visualization of Cre-expressing cell nuclei by
detection of b-galactosidase (b-gal) protein and projections
of the corresponding cells by green fluorescent protein
(GFP). Littermate control mice were used in all experi-
ments to ensure that any aberrant phenotypes were spe-
cifically dependent on the deletion of Vglut2 expression in
TH-Cre-expressing neurons. Further, the observer was
blind to the genotype of the mice until the final analysis
stage.
In situ hybridization and immunohistochemistry
Tissue preparation
Animals were mated overnight for production of cKO-Cre-
GFP and Ctrl-Cre-GFP offspring, and females were
checked for a vaginal plug the following morning.
Embryos were collected at embryonic (E) day 12 and 14. In
the morning of E19, pups were born and staged as P0. For
dissection of embryos, pregnant females were sacrificed by
cervical dislocation and embryos were removed. For col-
lection of adult brains, mice were sacrificed by cervical
dislocation and brains removed. Amniotic sac (from
embryos) and tails (from pups) were collected for geno-
typing according to protocols previously described (Wall-
e´n-Mackenzie et al. 2006). The tissue was fixed in zinc
formalin (Richard-Allan Scientific, Kalamazoo, MI) for
18–24 h at room temperature before dehydration and par-
affin infusion (Tissue Tek vacuum infiltration processor;
Miles Scientific, Elkhart, IN). Sections (7 lm thick) were
cut on a Microm microtome, attached to Superfrost slides
(Menzel-Gla¨ser, Braunschweig, Germany) and stored at
4 C until usage. Slides were then deparaffinized in X-tra
solve (MediteHistotechnic, Burgdorf, Germany) and rehy-
drated in ethanol/water before subsequent treatments.
In situ hybridization histochemistry
For paraffin in situ hybridization histochemistry, rehy-
drated paraffin sections were fixed for 10 min in 4 %
formaldehyde, washed in phosphate-buffered saline (PBS),
and treated with proteinase K (Sigma; 27 lg/ml diluted in
10 mM Tris–HCl/1 mM EDTA, pH 8.0) for 5 min. After
refixation and washes in PBS, the slides were acetylated for
10 min in a mixture of 1.3 % triethanolamine (Sigma),
0.2 % acetic anhydride (Fluka, Neu-Ulm, Germany), and
0.06 % HCl diluted in water. Slides were then incubated
for 30 min in PBS containing 1 % Triton X-100 (Sigma).
After subsequent washes in PBS, slides were prehybridized
for 2–5 h in hybridization solution without probe [50 %
formamide (Fluka), 59 saline-sodium citrate (SSC), 59
Denhardt’s, 250 lg/ml yeast transfer RNA (Sigma) and
500 lg/ml sheared salmon sperm DNA (Ambion, Austin,
TX, USA) diluted in water]. The probe for Vglut2 (cov-
ering nucleotides 1,616–2,203) was diluted to 0.1–1 lg/ml
in hybridization solution and heated to 80 C. Sections
were then hybridized with 100 ll of hybridization solution
for 16 h at 70 C. The next day, slides were dipped in
prewarmed 59 SSC, transferred to 0.29 SSC, and incu-
bated for 2 h at 70 C. After one wash in 0.29 SSC at
room temperature and one wash in B1 solution (0.1 M
Tris–HCl, pH 7.5, and 0.15 M NaCl), sections were
immuno-blocked with 10 % foetal calf serum in B1, and
then incubated overnight at 4 C with alkaline phospha-
tase-conjugated anti-digoxigenin Fab fragments (Roche,
Mannheim, Germany) diluted 1:5,000 in B1 containing
1 % foetal calf serum. The following day, slides were
washed in B1, equilibrated in B3 (0.1 M Tris–HCl, pH 9.5,
0.1 M NaCl, 50 mM MgCl2), and colour developed in a
10 % polyvinyl alcohol (Sigma) solution also containing
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100 mM Tris–HCl, pH 9.5, 100 mM NaCl, 5 mM MgCl2,
0.17 % nitroblue tetrazolium (Roche), 0.17 % 5-bromo-4-
chloro-3-indolyl phosphate (Roche), and 1 mM levamisole
(Sigma). Staining was sufficient after 6–24 h, whereupon
slides were washed in PBS and incubated overnight with
primary mouse TH (Chemicon) antibody and processed as
described below (omitting the boiling procedure).
Immunofluorescence histochemistry
For immunofluorescence histochemistry, rehydrated par-
affin sections were boiled (this step was omitted in
experiments of combined in situ hybridization and
immunofluorescence) for 10 min in 0.1 M citric acid
(VWR International, Leicestershire, UK), pH 6.0, left to
cool for 20–30 min, washed in PBS, and incubated with
primary mouse TH (Chemicon), rabbit b-gal (ICN/Cap-
pel), chicken GFP (Abcam), chicken and guinea pig
VGLUT2 [own production based on peptide sequences
described in (Hioki et al. 2003)] via Innovagen, Lund,
Sweden), rat Nestin (Dev Studies Hybridoma Bank),
rabbit vesicular inhibitory amino acid transporter (VIA-
AT; gift from Prof Bruno Gasnier (McIntire et al. 1997;
Sagne et al. 1997), mouse alpha-Internexin (Chemicon),
mouse b-III-Tubulin (TUJ1; Chemicon), rabbit Synapsin
(Chemicon), respectively, in PBS with 0.3 % Triton
X-100 at room temperature overnight. The following day,
slides were washed in PBS and incubated with Alexa
fluorescent secondary antibodies (Invitrogen, San Diego,
CA) diluted 1:200 in PBS with 0.3 % Triton X-100 and
10 % goat serum for 2 h at room temperature. Slides were
then washed in PBS, incubated with 1 lg/ml 40,60-di-
amidino-2-phenylindole (DAPI) (Sigma), washed again,
and mounted. Images were captured on a Zeiss LSM 510
Meta confocal microscope and analysed using Volocity
software (Improvision).
Combination of Vglut2 in situ hybridization and TH
immunolabeling
Coronal free-floating sections (10, 12 or 16 lm in thick-
ness) were processed as described previously (Wang and
Morales 2008). Sections were incubated for 10 min in
phosphate buffer (PB) containing 0.5 % Triton X-100,
rinsed 2 9 5 min with PB, treated with 0.2 N HCl for
10 min, rinsed 2 9 5 min with PB and then acetylated in
0.25 % acetic anhydride in 0.1 M triethanolamine, pH 8.0
for 10 min. Sections were rinsed 2 9 5 min with PB, post-
fixed with 4 % paraformaldehyde (PFA) for 10 min. Prior
to hybridization and after a final rinse with PB, the free-
floating sections were incubated in hybridization buffer
(50 % formamide; 10 % dextran sulfate; 59 Denhardt’s
solution; 0.62 M NaCl; 50 mM DTT; 10 mM EDTA;
20 mM PIPES, pH 6.8; 0.2 % SDS; 250 lg/ml salmon
sperm DNA; 250 lg/ml tRNA) for 2 h at 55 C. Sections
collected on glass slides were dehydrated through a series
of graded ethanol (50, 70 and 95 %, 5 min for each con-
centration). Sections were hybridized for 16 h at 55 C in
hybridization buffer containing [35S]- and [33P]-labelled
single-stranded antisense or sense Vglut2 (nucleotides
317–2,357, Accession # NM_053427) probes at 107 cpm/
ml. Sections were treated with 4 lg/ml RNase A at 37 C
for 1 h, washed with 19 SSC, 50 % formamide at 55 C
for 1 h, and with 0.19 SSC at 68 C for 1 h. After the last
SSC wash, sections were rinsed with PB and incubated for
1 h in PBS supplemented with 4 % bovine serum albumin
and 0.3 % Triton X-100. This was followed by overnight
incubation at 4 C with an anti-TH mouse monoclonal
antibody (1:500, MAB 318, Millipore, Billerica, MA) for
which specificity has been documented (Tagliaferro and
Morales 2008). After rinsing 3 9 10 min in PB, sections
were processed with an ABC kit (Vector Laboratories,
Burlingame, CA). The material was incubated for 1 h at
RT in a 1:200 dilution of the biotinylated secondary anti-
body, rinsed with PB, and incubated with avidin-biotinyl-
ated horseradish peroxidase for 1 h. Sections were rinsed
and the peroxidase reaction was then developed with
0.05 % 3, 3-diaminobenzidine-4 HCl (DAB) and 0.03 %
hydrogen peroxide. Free-floating sections were mounted on
coated slides. Slides were dipped in Ilford K.5 nuclear tract
emulsion (Polysciences, Inc., Warrington; 1:1 dilution in
double distilled water) and exposed in the dark at 4 C for
4 weeks prior to development. Slides processed for fluo-
rescent and bright-field histochemistry were analysed using
an Olympus (Tokyo, Japan) microscope with an Optigrid
system (Thales, Fairport, NY) and by confocal microscopy
using the Zeiss (Oberkochen, Germany) LSM 510 META
system. Images were captured using Volocity software
(Improvision, Lexington, MA) and captured images were
auto-levelled using Adobe Photoshop software. For cell
counting within the IF and RLi areas, an observer blind to
the genotype of the mice (1 cKO and 1 control) counted
TH-expressing, Vglut2-expressing and TH/Vglut2-express-
ing cells in 11 cKO and 9 control sections.
Single-cell RT-PCR
Brains were obtained from P1 cKO-Cre-GFP and Ctrl-Cre-
GFPmice following decapitation. A 1 mm thick coronal
slice, which contained the mesencephalon was prepared
under fluorescent microscope. Excess tissue was removed
until only the substantia nigra pars compacta (SNc) and
A10 areas, visualized by TH-Cre-driven GFP fluorescence,
remained. The tissue was collected in ice-cold dissociation
solution (90 mM Na2SO4, 30 mM K2SO4, 5.8 mM MgCl2,
0.25 mM CaCl2, 10 mM HEPES, 20 mM glucose, and
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0.001 % phenol red, pH 7.4) then digested with papain for
20 min at 37 C with agitation. The tissue was then tritu-
rated by several passages through glass pipettes of
decreasing diameter to obtain a cell suspension (see inset in
Fig. 8 for illustration of this procedure). The cells were
then centrifuged through a differential gradient to eliminate
dead cells and debris. Cells were plated on poly-L-lysine-
coated coverslips and left to adhere for 30 min at 37 C.
The coverslips were then washed with Krebs–Ringer buffer
(KRB) (140 mM NaCl, 5 mM KCl, 2 mM MgCl2, 2 mM
CaCl2, 10 mM HEPES, 10 mM glucose, 6 mM sucrose,
pH 7.35) to eliminate non-attached cells and in KRB dur-
ing single cell collection. GFP-expressing cells were ran-
domly collected to avoid a selection bias towards cells that
express high levels of GFP. All cells were collected indi-
vidually using autoclaved borosilicate patch pipettes under
RNAse-free conditions; each cell was collected by apply-
ing light negative pressure to the pipette, no intracellular
pipette solution was used. The content of each pipette was
transferred into individual pre-chilled tubes containing a
freshly prepared solution of 20 U of RNase inhibitor and
8.3 mM DTT, samples were frozen immediately on dry ice
and stored at -80 C until use. The samples were thawed
on ice and the RNA converted to cDNA by reverse tran-
scription for 1 h using 0.5 mM dNTPs mix, 1.25 lM ran-
dom primers, 40 U of RNase inhibitor, 100 U of M-MLV
RT (Invitrogen), 50 mM Tris-HCl, 75 mM KCl and 3 mM
MgCl2, pH 8.3. The RT enzyme was denatured and the
cDNAs stored at -80 C until use. A first round of PCR
was performed using 1.5 mM MgCl2, 10 pmol of each
primer, 1.0 U of platinum Taq-DNA polymerase (Invitro-
gen), 20 mM Tris–HCl and 50 mM KCl pH 8.4. Thermal
cycles consisted of an initial denaturation step of 94 C for
2 min, followed by 35 cycles of 94 C for 50 s, 55 C for
45 s and 72 C for 45 s. A second nested PCR was then
performed as mentioned above using 10 % of the first PCR
reaction as template. All PCR products were resolved on
2.5 % agarose gels. Primers were designed based upon
sequences deposited in the GenBank database (www.ncbi.
nlm.nih.gov/nucleotide). The Vglut2 primers were
designed around exons 4, 5 and 6 to detect both the wild-
type and the knockout allele. TH and DAT mRNA
expressions were also investigated. The oligonucleotides
used were Vglut2: first round sense 5´-gccgctacatcatag
ccatc-3´ and antisense 5´-gctctctccaatgctctcctc-3´, nested
sense 5´-acatggtcaacaacagcactatc-3´ and antisense 5´-ataag
acaccagaagccagaaca-3´; TH: first round sense 5´-gttctcaa
cctgctcttctcctt-3´ and antisense 5´-ggtagcaatttcctcctttgtgt-3´,
nested sense 5´-gtacaaaaccctcctcactgtctc-3´ and antisense
5´-cttgtattggaaggcaatctctg-3´; DAT: first round sense 5´-ttcact
gtcatcctcatctctttc-3´ and antisense 5´-gaagctcgtcaggga
gttaatg-3´, nested sense 5´-gtattttgagcgtggtgtgct-3´ and anti-
sense 5´-gatccacacagatgcctcac-3´.
Behavioural studies
Spontaneous and amphetamine-induced locomotor activity
To assess spontaneous and amphetamine-induced activity,
mice were placed in automated activity chambers, so-
called Locoboxes, consisting of a plastic cage
(55 9 55 9 22 cm) inside a ventilated and illuminated (10
lux) cabinet (Locobox, KungsbackaMa¨t- ochReglerteknik
AB) in which activity was recorded as the following
parameters: corner time, horizontal locomotion, vertical
locomotion (rearing) and peripheral activity. After 30 min
of baseline recording, mice received an intraperitoneal
injection of saline and their locomotive activity was
recorded for a further 90 min. To assess their drug-induced
behaviour, 2–3 days after the saline injection, the same
procedure was followed, but the mice were instead given
an intraperitoneal injection of 1.5 mg/kg amphetamine.
Data analysis was performed using the GraphPad Prism
software (GraphPad Software Inc., La Jolla, USA).
The radial arm maze
The radial arm maze is a hippocampus-dependent task used
to record spatial working memory (WM), in which the
ability of the mouse to remember the location of food-
baited versus unbaited arms is measured (Meck et al.
1984). Spatial memory performance was examined in 24
cKO mice and littermate controls, all males using an eight-
armed radial maze (see Fig. 5 for illustration of the radial
maze and the parameters scored). The maze, elevated
45 cm above the floor, consisted of eight open arms (60 cm
long and 12.5 cm wide, surrounded by inclining walls at a
height of 13 cm at the centre and 3 cm at the end of the
maze arms) radiating from a central compartment (30 cm
in diameter). A podium (10 9 4 cm) with a recessed food
plate (diameter 3 cm) was fixed at 1.5 cm from the end of
each of the maze arms. Three days prior to the beginning of
the experiment, the mice were schedule-fed for 6 h/day,
which was reduced to 2 h/day at the start of the behavioural
studies. Four of the eight arms were baited with the pre-
ferred food, R6-38, consisting of a high content of theo-
broma cacao. For the acquisition period, the animals were
placed individually in the centre of the maze once each day
for 5 days. The animals were allowed to perform for
10 min on the first trial day and thereafter the animals were
allowed to remain in the apparatus until all reinforcements
were obtained or until 10 min had elapsed, whichever
occurred first. The same four arms were baited with a small
piece of reinforcement food pellet each day. Nineteen days
after the last acquisition session a retention test was per-
formed. The same arms were baited and the mice again the
same procedure was followed. The mice were manually
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scored for performance during the trial time. For scoring,
an entry half way into an arm was defined as an arm entry.
For each trial, a reference memory error (RME) was
defined as a visit into an unbaited or incorrect arm. A
working memory error (WME) was defined as a re-entry
into an arm in which the reward was already obtained
during the session. The total number of entries into each
arm and the percentage of correct responses were also
scored. Results were analysed using StatView 5.0 for
Windows. A 2 9 2 9 6 (genotype 9 sex 9 trial days)
two-way repeated-measures ANOVA was used to assess
RME, WME, total number of arm entries and the per-
centage of correct responses obtained during trial period.
Test day was analysed by Student’s t test.
High-pressure liquid chromatography (HPLC)
with electrochemical detection
Brains were obtained from cKO and littermate control mice
(7 Ctrl, 7cKO) following euthanasia by cervical disloca-
tion. The brains were put in a 1 mm coronal mouse brain
matrix (Ted Pella Inc, Redding, CA, USA) kept on ice and
sliced. The olfactory bulb, a combination of the substantia
nigra and the ventral tegmental area (VTA/SNc), hypo-
thalamus, nucleus accumbens (NAcc), caudate putamen
(CaPu), prefrontal cortex (PFC), amygdala and hippo-
campus were excised from the slices, weighed and stored at
-80 C. The tissue was subsequently homogenized by
sonification in 0.1 M perchloric acid solution (50 mg
(1.6 mM) glutathione; 1.5 g (149 mM) 70 % PCA; 100 ml
H2O). The homogenates were centrifuged at 4 C for
15 min at 12,0009g and the supernatant recovered for
analysis of DA and its metabolites 3,4-dihydroxyphenyl-
acetic acid (DOPAC) and homovanillic acid (HVA) con-
tent by HPLC. 40–50 ll of the supernatant was injected
onto the HPLC column with the current set to 50 nA for all
samples. A mobile phase (containing 55 mM sodium ace-
tate, 0.01 mM EDTA, 1.16 mM 1-octanesulfonic acid
sodium salt, 10 % methanol, pH 4) was used to separate the
analytes. Chromatograms were captured using the Azure
program (Kromatek, Essex, England) and the pmol values
of the peaks were calculated from a standard curve for each
DA, DOPAC and HVA. All statistical analyses of the data
were performed using GraphPad Prism 5.0 software. Out-
liers were identified using the Grubbs test and excluded
from the analysis. The concentration of each metabolite
was compared between the cKO and littermate control
mice using the Mann–Whitney U test.
Electrophysiology
In vitro local field potential (LFP) recordings from hippo-
campus slices were performed as previously described
(Leao et al. 2009). Following decapitation under isoflurane
anaesthesia, brains of P18-P25 cKO and littermate control
mice were removed from the skull and placed in ice-cold
high-sucrose artificial cerebrospinal fluid (ACSF) (in mM:
KCl, 2.49; NaH2PO4, 1.43; NaHCO3, 26; glucose, 10;
sucrose, 252; CaCl2, 1; MgCl2, 4). A vibratome (VT1000,
Leica Microsystems) was used to obtain horizontal hip-
pocampal slices that were moved to a submerged recording
chamber containing ACSF (in mM: NaCl, 124; KCl, 3.5;
NaH2PO4, 1.25; MgCl2, 1.5; CaCl2, 1.5; NaHCO3, 30;
glucose, 10), constantly bubbled with 95 % O2 and 5 %
CO2 and kept at 35 C for 1 h then maintained at room
temperature. For LFP recordings, slices were transferred to
an interface-type chamber and kept at 35 C (Zelano et al.
2013). A recording glass pipette filled with ACSF was
placed in the stratum radiatum of CA3. LFP signals were
amplified 1009 using custom-made amplifier (John Curtin
School of Medical Research, Australian National Univer-
sity), low-pass filtered at 3 kHz and digitized at 10 kHz by
a National Instruments DAQ card. Data were analysed
using Matlab (Mathoworks).
Results
Vglut2 expression in TH and non-TH-expressing cells
in the embryonic VTA area
We have previously shown that Vglut2 is prominently
expressed in the subventricular zone in several cortical,
subcortical and brainstem structures, including in TH-
expressing neurons in the ventral midbrain, of the mouse
already at midgestation (Birgner et al. 2010). To analyse if
Vglut2 gene expression at these early developmental stages
results in protein products, we analysed localization of the
VGLUT2 protein in combination with a range of various
molecular markers by immunohistochemistry (IHC).
Ample VGLUT2 protein was found in the di-, mes- and
metencephalon of the developing mouse brain already at
E12, detected in the distinct, dotted appearance of pre-
synaptic structures where it colocalised with the presyn-
aptic marker Synapsin (Fig. 1a, representative example).
VGLUT2 protein did not colocalize with Nestin, a marker
for dividing neural progenitor cells (Lendahl et al. 1990)
(Fig. 1b), but was detected in elongated structures resem-
bling fibre bundles, where it showed some, but not com-
plete colocalization with alpha-Internexin (Fig. 1c), a class
IV intermediate filament protein commonly used as a
marker for subclasses of neurons and the general neuronal
fibre marker beta-III-Tubulin (TUJ1) (Fig. 1d). These fibre
structures are usually not observed when analysing
VGLUT2 protein immunoreactivity in the adult brain,
where it is exclusively presynaptic and vesicular,
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Fig. 1 Immunohistochemical
and in situ hybridization
analysis on sagittal sections of
the embryonal mouse brain.
Immunofluorescent analysis of
VGLUT2 (red) with cell nuclei
labelled with DAPI (blue) at
embryonic (E) day 12. Synaptic
colocalization of VGLUT2
(red) and Synapsin (green) (a);
Nestin-expressing neuronal
progenitors (green) interspersed
with VGLUT2 (red) (b);
localization of VGLUT2 (red)




(c left and right); localization of
vesicular VGLUT2 (red dots)
within neuronal fibre bundles
labelled by b-III-Tubulin (Tuj1;
green) (d); overview (E15) of
ventral midbrain (VM) to
visualize the area above
mesencephalic flexure (MF) and
TH-positive (green) neurons
with projections in median
forebrain bundle (MFB) to
striatum (e), dotted square
marks the area of sections
shown in f, g; VGLUT2-
positive fibres (note, green) in
the VM above the MF, no
colocalization with the marker
for inhibitory neurons, VIAAT
(red) (f); VGLUT2-positive
fibres (red) in VM area of TH-
positive neurons (green) (g);
(h) in situ hybridization
combined with
immunohistochemistry of
Vglut2 mRNA (black) and TH
protein (green) in the VM.Cells
positive for both Vglut2 (black)
and TH (green) marked with
single asterisk cells positive for
Vglut2 but not TH marked with
hash
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suggesting that VGLUT2 is present in the embryo already
during the establishment of the developing axonal struc-
tures. When analysing the ventral midbrain (Fig. 1e for
localization of area), VGLUT2 was found not to colocalize
with VIAAT, a molecular marker for inhibitory neurons
(Fig. 1f). TH-expressing neurons were found intermingled
with VGLUT2-positive fibres, suggesting ample glutama-
tergic afferent input into this area (Fig. 1g). With the
reports of a ‘‘Glu-only’’ neuronal population in the adult
VTA (Hnasko et al. 2012; Kawano et al. 2006; Li et al.
2013; Yamaguchi et al. 2007), we wished to assess Vglut2
expression in the ventral mesencephalic flexure where
VTA and SNc neurons form (Wang et al. 1995; Ye et al.
1998). Vglut2 in situ hybridization analysis at E12 com-
bined with IHC for TH showed a mixture of cells
expressing both Vglut2 and TH (‘‘TH–Vglut2’’), cells
expressing Vglut2 but not TH (‘‘Vglut2-only’’), and cells
expressing TH but not Vglut2 (‘‘TH-only’’) at all three
embryonal stages examined (Fig. 1h for representative
example, and Fig. 8 for illustration of these populations).
Together, these analyses show that the Vglut2 gene is
expressed from midgestation and onwards in the develop-
ing mouse brain, including the developing VTA area where
it is found in both TH-expressing and non-TH-expressing
cells.
TH-Cre activity detected in ‘‘TH-only’’, ‘‘TH–Vglut2’’
and ‘‘Vglut2-only’’ VTA neurons
The tau-mGFP floxed Cre-reporter (Hippenmeyer et al.
2005) was used to enable validation of Cre activity in the
previously described TH-Cre knock-in mouse (Lindeberg
et al. 2004) by IHC for b-galactosidase (b-gal) and green
fluorescent protein (GFP) in the same sections to detect
TH-Cre-expressing cell nuclei (b-gal) and projec-
tions(GFP) throughout the adult brain. By analysis of Ctrl-
Cre-GFP mice (see Materials and Methods for description),
we could confirm the previous characterization of the TH-
Cre mice (Lindeberg et al. 2004) which, using the loxP-
STOP-loxP-LacZ (Tsien et al. 1996), showed TH-Cre-
activity in all catecholaminergic cell groups, including the
noradrenergic neurons of the A1, A2 and locus coeruleus
groups, the adrenergic neurons of the C1, C2 and C3
groups in the medulla, in addition to the DA cell groups in
the ventral midbrain (A8, A9, A10) and hypothalamus
(A11-13) (data not shown). We could also confirm previ-
ous observations of TH-Cre activity in the dorsal root
ganglia (Lagerstro¨m et al. 2010; Lindeberg et al. 2004), but
in contrast to the previous characterization (Lindeberg
et al. 2004), we did not detect TH-Cre activity, assessed by
b-gal-IHC, in the cortex or hippocampus (data not shown).
However, as described below, the hippocampus did contain
GFP-immunoreactive fibres, confirming innervation from
TH-Cre-expressing neurons located elsewhere (shown in
Fig. 2b and also in Fig. 7a). We then focused our analyses
on the ventral midbrain. By analysing GFP IHC in sagittal
sections, we detected median forebrain bundle projections
reaching from the VTA/SNc area to the dorsal and ventral
striatum (Fig. 2a). Combined b-gal (‘‘reporting’’ TH-Cre
transgene activity) and TH (endogenous TH protein) IHC
on coronal sections visualized the two markers in the A10
area (2C-D), with high-level magnification showing b-gal
in the nuclei of TH-immunoreactive neurons (Fig. 2c–e).
In addition, in the IF and RLi areas, where we (Fig. 3) and
others (Hnasko et al. 2012; Li et al. 2013) detected Vglut2-
expressing cells that did not express endogenous TH,
several b-gal-positive cell nuclei were detected that lacked
TH-immunoreactivity (Fig. 2b–d). Although somewhat
surprising, these findings are in accordance with the ori-
ginal characterization of the TH-Cre transgene (Lindeberg
et al. 2004)which found that due to early and transient
expression from the TH promoter during development, the
Cre transgene will be active early on in cells not expressing
stable endogenous TH later in life (see Fig. 8 for illustra-
tion of the TH promoter activity). This seemingly ectopic
Cre activity will give rise to early deletion of any floxed
alleles present and which will remain gene targeted
throughout their life, thereby providing a molecular
mechanism for how adult A10 cells can be immunopositive
for b-gal but not TH. Based on this finding, we hypothe-
sized that mice expressing both TH-Cre and the floxed
Vglut2 allele, i.e. Vglut2f/f;TH-Cre? mice, should have
Vglut2 gene targeted in both ‘‘TH–Vglut2’’ cells and in
‘‘Vglut2-only’’ cells.
Vglut2 mRNA in the adult VTA area verified
in TH- and non-TH-expressing cells
Previous studies have identified highest ventral midbrain
Vglut2 expression in DA neurons of the medial A10 area,
including the IF and RLi (see Fig. 3a for illustration) of the
cFig. 2 TH-Cre transgene analysis in the adult mouse brain via the
tau-mGFP double Cre-reporter. Cell nuclei marked with DAPI (blue)
( a). Projections from the ventral tegmental area and substantia nigra
pars compacta (VTA/SNc) to the entire striatal area (left) via the
median forebrain bundle (MFB) visualized by immunofluorescence
for the green fluorescent protein (GFP), close-up of GFP fibres in the
hippocampus (right) (a). Nuclear b-galactosidase (b-gal; red) shows
the position of cells in which TH-Cre activity has enabled b-gal
expression; endogenous TH protein expression is indicated by TH
immunoreactivity (green); co-localization (b-gal (red) nuclei in
centre of TH (green) cytoplasm) is mainly seen in medial (m) and
lateral (l) VTA, less so in the medially located rostral linear nucleus
(RLi) and Interfascicular nucleus (IF) where many cells show b-gal
(red) only (b, c). Triple b-gal (red)/TH (blue)/GFP (green) immu-
nofluorescence in RLi shows some b-gal/GFP-positive TH-Cre-
reporting cells that immunopositive for TH (hash) and some that do
not have TH (single asterisk) (d left and close-up to the right)
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adult mouse and rat, intermingled with Vglut2-only
expressing cells (Hnasko et al. 2012; Li et al. 2013;
Yamaguchi et al. 2007). Based on these studies, we
addressed Vglut2 expression in the ventral midbrain of the
adult mouse of C57/BL6-Sv129 mixed genetic background
and could confirm these previous reports (Hnasko et al.
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2012; Li et al. 2013; Yamaguchi et al. 2007). Vglut2 in situ
hybridization combined with IHC for TH showed a mixture
of cells expressing both Vglut2 and TH (‘‘TH–Vglut2’’),
cells expressing Vglut2 but not TH (‘‘Vglut2-only’’), and
cells expressing TH but not Vglut2 (‘‘TH-only’’, presum-
ably classical DA neurons) in the adult A10 area (Fig. 3b–
d). We next counted the number of TH-expressing (Mean/
SEM IF: Ctrl 33.6/8.6; cKO 34.3/10.0, RLi: Ctrl 10.9/4.8;
cKO 5.1;1.2), Vglut2-expressing (Mean/SEM IF: Ctrl 8.3/
3.4; cKO 4.1/1.1, RLi: Ctrl 29.0/8.6; cKO 16.5/3.3) and
TH/Vglut2-expressing (Mean/SEM IF: Ctrl 0.3/0.2; cKO
0.3/0.1, RLi: Ctrl 1.8/0.5; cKO 2/1.4) cells, respectively, in
the IF and RLi areas of control (9 sections) and cKO (11
sections) mice in the Vglut2f/f;TH-Cre mouse line, but due to
loss of material failed to reach a statistically relevant
evaluation.
The TH-Cre transgene mediates deletion
in ‘‘TH–Vglut2’’ and ‘‘Vglut2-only’’ neurons
To further analyse gene expression in TH-Cre-active cells,
we turned to single-cell RT-PCR experiments in freshly
dissociated GFP-positive cells derived from the dissected
VTA/SNc area using Vglut2 primers designed to distin-
guish between the wildtype and knockout alleles (Fig. 4a).
Sixty GFP-expressing cells were collected and prepared
from P1 Ctrl-Cre-GFP and cKO-Cre-GFP mice, respec-
tively (Fig. 8 for illustration). As expected, none of the
green cells picked from the Ctrl-Cre-GFP mice expressed
the Vglut2 knockout allele, instead all 12 cells expressing
Vglut2 showed the wildtype allele (representative examples
shown in Fig. 4b). In contrast, Vglut2 expression in the
cKO-Cre-GFP was represented almost exclusively by the
knockout allele; in 28 out of 29 (97 %) Vglut2-expressing
cells recombination had occurred leading to a deletion of
Vglut2, thus verifying the conditional targeting of Vglut2
(representative examples shown in Fig. 4b). In addition,
primers for endogenous TH and DAT expression were used
to further characterize the GFP-expressing cells. Out of 60
cells, 48 cells (80 %) were found to be expressing
bFig. 3 Localization of TH protein and Vglut2 mRNA by combined
immunohistochemistry and in situ hybridization in coronal section of
the adult mouse midbrain. Representative section at Bregma -3.16.
Illustration of anatomically distinct A10 areas, including the rostral
linear nucleus of the raphe´ nuclei (RLi); paranigral nucleus (PN);
interfascicular nucleus (IF); parabrachial pigmented nucleus (PbP);
also marked is the substantia nigra pars compacta (SNc); substantia
nigra pars reticulata (SNr). The cerebral peduncle (CP) and third
ventricle (3 V) were added as landmarks a; Overview of ventral
midbrain showing Vglut2 mRNA broadly dispersed (grey) and TH-
immunoreactivity (brown) in A10 and SNc areas, with the above
outlined structures as overlay (black dotted outline) and indicating the
area of the close-ups below (orange dotted line) (b). Close-up images
of the RLi and IF as indicated in B (orange outline) showing TH-
immunoreactivity (brown) and Vglut2 mRNA (light green) (c) and
Vglut2 mRNA detected as silver grains (d). Arrows denote the same
neurons in both panels; the upper arrow indicating a neuron positive
for both TH and Vglut2, the lower arrow indicating a neuron positive
for TH only
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endogenous TH. Of these 48 cells, 13 cells (22 % of all
cells) were coexpressing TH and DAT but did not contain
Vglut2 (presumably classical DA neurons), 5 cells (8 % of
all cells) were coexpressing TH, Vglut2 and DAT (possibly
‘‘TH–Vglut2 Class 1’’ neurons) and 18 cells (30 % of all
cells) were found to be coexpressing TH and Vglut2
(possibly ‘‘TH–Vglut2 Class 2’’ neurons). Further, six GFP-
expressing cells (10 %) were also identified which
expressed Vglut2 but not TH or DAT (possibly ‘‘Vglut2-
only’’ neurons). Representative examples of RT-PCR gene
products are shown in Fig. 4b.
These results show that in cells expressing the TH-Cre
transgene in the VTA/SNc area, as identified by green
fluorescence, Vglut2 expression is found in ‘‘Vglut2-only’’
cells and in both populations of cells expressing TH, i.e.
those expressing Vglut2 together with both TH and DAT,
and those expressing Vglut2 together with TH only (See
Fig. 8 for illustration). Vglut2 was identified as gene tar-
geted (knocked out) within all three populations of VTA-
VGLUT2 neurons. Furthermore, the results indicate that
recombination has occurred in nearly 100 % of all picked
GFP-positive neurons of the mesencephalon expressing
Vglut2. This level of recombination is in accordance with
our previous characterization showing gene targeting in
74 % of the Vglut2-expressing cells of the dorsal root
ganglia (DRG) in the same mouse line (Lagerstro¨m et al.
2010). In comparison, 82 % of DAT-Cre-expressing cells
which also expressed Vglut2 showed targeting of the
Vglut2 allele in the previously characterized Vglut2f/f;DAT-Cre
mouse line (Birgner et al. 2010).
Fig. 4 Targeting construct and
single-cell RT-PCR analysis.
a Illustration of the genomic
DNA sequence showing the
Vglut2 locus in a wildtype
mouse (uppermost panel),
followed by the mRNA
generated from the wildtype
(WT) floxed allele that has not
seen TH-Cre activity (middle),
and the mRNA of the
conditional knockout allele
generated after TH-Cre-activity
has excised the DNA sequence
between the LoxP (P) sites
(lower panel). The Vglut2
primers for RT-PCR analysis on
single cell material were
designed around exons 4 and 6
to detect both the wildtype and
knockout (KO) allele, the
primer annealing sites for nested
RT-PCR are indicated below the
transcript as follows: first round
in middle panel, second round
in lower panel. b Representative
example of a gel picture
showing final RT-PCR products
in single cell material (derived
from GFP fluorescent, dissected
VTA/SNc P1 conditional
knockout (cKO) and control
brains, resp.);Vglut2 (WT allele
506 bp, uppermost band; KO
allele 372 bp, lowermost band),
TH and DAT, all as indicated to
the right of the picture
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Behavioural analysis reveals a normal
amphetamine-induced activational response
but decreased spatial memory
We have previously described that the Vglut2f/f;TH-CrecKO
mice are fully viable but that TH-Cre activity in the DRG
leads to an itch phenotype in some Vglut2f/f;TH-CrecKO
mice at a late adult stage (Lagerstro¨m et al. 2010). This
viable phenotype suggests absence of gross dysfunction in
medullary cardiorespiratory functions, despite a presumed
loss of Vglut2 expression in C1-3 adrenal cell groups. For
behavioural phenotyping of the Vglut2f/f;TH-CrecKO mice,
we used mice around 7–8 weeks of age that did not show
any itch-related phenotypes. To allow a comparison
between the Vglut2f/f;TH-Cre and the Vglut2f/f;DAT-Cre mouse
lines, which differ somewhat spatiotemporally in their
targeting as described above, we performed the same
behavioural tests of relevance to DA function as we pre-
viously performed on the Vglut2f/f;DAT-Cre mouse line
(Birgner et al. 2010) analysing reward-related function as
well as affective and cognitive function, respectively. The
tests included: psychostimulant-induced activational
response, the forced swim test (FST), the elevated plus
maze (EPM) and the radial maze. Spontaneous and
amphetamine-induced activities were recorded in activity
chambers, revealing no statistically significant differences
between cKO and control mice, either pre- or post-injec-
tion, in either vertical or horizontal locomotion, or the time
spent in peripheral versus central areas of the chamber
(Fig. 5a, b and data not shown). Further, no differences
between genotypes were observed in the FST in which the
cKO and control mice spent equal time swimming in a two-
day trial experiment (Supplementary Fig. 1A). In the EPM,
no differences between genotypes were seen in time spent,
or number of entries, in any area (Supplementary Fig. 1B).
Analysis of the total number of entries during the entire
trial showed no differences between genotypes, suggesting
that the total activity of the mice is the same for both
genotypes (Supplementary Fig. 1B).
The eight-armed radial maze (illustration Fig. 5c) was
utilized to determine whether there was any impairment in
hippocampus-dependent spatial memory (Meck et al. 1984)
performance in the cKO mice. The overall performance of
the mice in the maze task was determined by the per-
centage of correct responses. Both the cKO and the litter-
mate control mice increased their efficiency throughout the
trials [F(1,100) = 12.558, p\ 0.0001]. However, cKO
mice took significantly longer to acquire the task in com-
parison to the littermate controls [F(1,20) = 8.369,
p = 0.009] (Fig. 5d). There was no difference in the
retention (18 days post-acquisition) of the learned task
between the two genotypes (Fig. 5d). Reference memory
error (RME) and working memory error (WME) were also
investigated in the task (Fig. 5e, f). There was a significant
overall difference in spatial processing throughout the trial
days for both RME [F(5,100) = 12,234, p\ 0.0001] and
WME [F(5,75) = 3.645, p = 0.0053]. cKO mice made
significantly more RMEs in comparison to the littermate
control mice across the trial days [F(1,20) = 5.605,
p = 0.0281] (Fig. 5e), whereas WMEs were not signifi-
cantly different in the two groups [F(1,15) = 3.504,
p = 0.0809] (Fig. 5f). No differences were seen between
the two genotypes in either the RME or WME on day 23
(Fig. 5e, f).
Taken together, this data show that Vglut2f/f;TH-CrecKO
mice lack alterations in depression-like and anxiety-like
behaviour as measured by the FST and the EPM paradigm,
respectively. These behavioural phenotypes mimic those of
the Vglut2f/f;DAT-Cre cKO mice characterized previously
(Birgner et al. 2010), as does the finding of normal levels of
total activity, detected both in the activity chambers prior
to injection of psychostimulant, and in the EPM. In con-
trast, Vglut2f/f;TH-CrecKO mice lack the altered response to
the psychostimulant amphetamine, which is evident in the
Vglut2f/f;DAT-Cre cKO mice, but show an impairment in the
acquisition of the radial maze task and performed more
spatial RMEs than control mice. Spatial memory functions
are mediated by the hippocampus and were previously
found normal in the Vglut2f/f;DAT-Cre cKO mice. Thus, the
targeting of Vglut2 expression by TH-Cre does not produce
the identical phenotype as corresponding targeting by
DAT-Cre, a finding likely reflected by the herein identified
fact that TH-Cre and DAT-Cre differ quite substantially in
their targeting of floxed Vglut2 cells.
HPLC analysis reveals altered DA levels
in the hippocampus
The VGLUT2 protein has been suggested to play a role in
DA transmission by affecting vesicular packaging of DA
by a process termed ‘‘vesicular synergy’’, a concept which
postulates that a VGLUT may work in synergy with
another vesicular transporter, such as the monoamine
transporter VMAT2, to increase the efficiency of this
transporter (Gras et al. 2008). We and others have previ-
ously shown that loss of VGLUT2 in DA neurons in the
Vglut2f/f;DAT-Cre mouse line leads to decreased DA release,
possibly, but not conclusively, supporting the concept of
vesicular synergy between VGLUT2 and VMAT2 (Alsio¨
et al. 2011; Hnasko et al. 2010). To assess if the targeted
loss of VGLUT2 would affect DA levels in the Vglut2f/f;TH-
Cre mouse line, HPLC was used to assess possible differ-
ences in the concentration of DA as well as its metabolites
DOPAC and HVA in cKO and control mice. This analysis
was carried out in a number of different brain regions,
including the VTA/SNc area, the olfactory bulb and the
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Fig. 5 Analysis of basal and amphetamine-induced locomotion and
of spatial memory. Horizontal locomotion (recorded as at least two
consecutive photobeam interruptions) before and after saline- (a) and
amphetamine- (b) injections; shown 30 minutes prior to injection
(-30 to -10), injection indicated by time point 0, and 90 min post-
injection (10–90) in 10 min intervals. Spatial memory testing in the
baited radial arm maze. Schematic drawing of the maze depicting a
correct choice (left), a reference memory error (RME) (middle) and a
working memory error (WME) (right) (see materials and methods for
details) (c). Performance of the mice during the acquisition days (1–5)
and retention testing (day 23) as indicated by the number of correct
choices (left), RMEs (middle) and WMEs (right) (d). Single asterisk
p\ 0.05; double asterisk p\ 0.001(2-way ANOVA)
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hypothalamus, all of which contain DA neuronal cell
bodies, as well as the nucleus accumbens (NAcc), caudate
putamen (CaPu), prefrontal cortex (PFC), amygdala and
the hippocampus as these regions are known target areas of
DA neurons. No difference was observed in DA, DOPAC
or HVA concentrations in the olfactory bulb, VTA/SNc,
CaPu, NAcc, hypothalamus or the PFC between cKO and
littermate control mice (Fig. 6a–f). However, a significant
increase was observed in DOPAC concentration in the
amygdala of cKO mice in comparison to controls
Fig. 6 HPLC analysis of DA
and its metabolites in dissected




acid (HVA) of control (white
bars) and cKO (grey bars) mice,
all in ng/g wet tissue. Olfactory




accumbens (NAcc) (d); caudate
putamen (CAPu) (e); prefrontal
cortex (f); amygdala (g);
hippocampus (h). Single
asterisk p\ 0.05; double
asterisk p\ 0.001 (Mann–
Whitney U test)
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(p = 0.0426), but not in DA or HVA (Fig. 6g). In contrast,
the concentration of DA (p = 0.0311), DOPAC
(p = 0.0489) and HVA (p = 0.0022) was all significantly
reduced in the hippocampus of cKO mice in comparison to
littermate controls (Fig. 4h).
The observations of reduced DA tissue levels in the
hippocampus support our behavioural observation of a
possible alteration in the hippocampus due to the lack of
Vglut2 expression in TH-Cre active cells.
Hippocampus slices from cKO mice show increased
kainate-induced excitability
As mentioned above, Ctrl-Cre-GFP mice show ample TH-
Cre-dependent projections throughout the hippocampal
formation (Fig. 7a, b), and behavioural phenotyping using
the radial maze for assessment of spatial memory function
suggests an impairment in the hippocampus. Signalling
between the VTA and hippocampus, especially DA release
in the hippocampus, has been shown to be important for the
formation of long-term memory (Lisman and Grace 2005).
The VTA is furthermore involved in the generation of
rhythmic activity in the hippocampus (Orzeł-Gryglewska
et al. 2012). We, therefore, hypothesized that the pattern of
network oscillations could be altered in cKO mice. To
investigate this, we recorded local field potential (LFP)
in vitro in the CA3 area of the hippocampus by using
horizontal slices (Leao et al. 2009). In slices derived from
control mice, 100 nM kainate application produced stable
gamma oscillations (7 in 8 slices from 3 animals, Fig. 7c)
and epileptic-like events (Zelano et al. 2013) in one of the
slices. In contrast, slices from cKO mice showed profound
changes in excitability when perfused with 100 nM kainate
(Fig. 7d–f). Kainate application elicited gamma oscillation
in only one slice (n = 8 slices from 3 animals, p = 0.01,
Z test) while epileptic-like events were recorded in the
remaining 7 slices (n = 8 slices from 3 animals,
p = 0.003, Z test, Fig. 7d–f).
These profound differences in CA3 responses to kainate
challenge indicate an impairment of cKO mice in the
ability to generate stable network oscillations.
Discussion
The present study focused on investigating the function of
Vglut2 expression in neurons that either transiently or
stably also express TH, the rate-limiting enzyme for cate-
cholamine synthesis. We found that the targeted deletion of
Vglut2 in TH-expressing neurons resulted in a memory
Fig. 7 Local field potential (LFP) recordings in the CA3 of the
hippocampal slice preparation. Immunofluorescent analysis of coro-
nal hippocampal sections. Overview of hippocampus regions [CA1,
CA2, CA3 and dentate gyrus (DG)] with cell bodies visualized by
DAPI (blue) (a); higher magnification close-up image of the CA3
region revealing projections labelled with green fluorescent protein
(GFP; green) from TH-Cre-reporter activity, cell bodies marked with
DAPI (blue) (b). LFP recordings of the CA3 region of hippocampal
slices taken from Control and cKO mice; representative example of a
control slice showing stable gamma oscillations (c); three examples of
different forms of epileptiform activity observed in CA3 slices of
cKO mice (d–f)
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formation-deficit observed as an increased time required to
acquire hippocampus-dependent spatial memory and ele-
vated amount of errors produced in the radial arm maze, a
finding which could possibly be associated with the
observations of decreased DA levels and altered firing
pattern in CA3 neurons of the hippocampus.
The role of glutamatergic signalling in cells that express
Vglut2 has been investigated using the Cre-LoxP-based
conditional knockout technique (Walle´n-Mackenzie et al.
2010). A full Vglut2 knockout mouse, driven by the PGK-
Cre transgene, resulted in dysfunctional glutamatergic
transmission in the pre-Bo¨tzinger complex causing neo-
natal lethality due to immediate respiratory failure, thereby
demonstrating that Vglut2 expression is necessary for post-
uterine life (Walle´n-Mackenzie et al. 2006). In our exten-
ded analysis of VGLUT2 at a midgestational embryonic
stage (E12), we now show that this protein is found
throughout the brain already at this early developmental
stage, putatively supporting a broader role in establishment
of the nervous system than previously recognized, but
which could gain from further exploration. For gene tar-
geting of Vglut2 expression within DA neurons specifi-
cally, DAT-Cre transgenic mice, of which there exists a
couple of variants, have been used by breeding to floxed
Vglut2f/f mice, of which there also exist a few variants
(Birgner et al. 2010; Fortin et al. 2012; Hnasko et al. 2010).
Data have generally been interpreted based on the
assumption that DAT-Cre will be active in all DA neurons
and similar assumptions are common in neighbouring
research fields where DAT-Cre mice are used to target
other gene expression in DA neurons [e.g. the selective
targeting of components of the glutamatergic machinery;
reviewed in Rodriguez Parkitna and Engblom (2012)].
However, it is well known that not all TH-expressing
neurons of the VTA area express DAT (Lammel et al. 2008;
Sesack et al. 1998). Thus, via DAT-Cre-mediated deletion
of Vglut2 in DA neurons, which gives rise to altered
responses to both sugar-rich food and psychostimulants,
the so-called ‘‘TH–Vglut2 Class 2’’ population, which lacks
DAT expression, has probably remained undisturbed, and
the observed reward-related phenotype has been due to
targeted deletion of Vglut2 in the ‘‘TH–Vglut2 Class 1’’
population only. As curious as this is, the situation
becomes slightly more complex when using a TH-Cre
transgene, as we did here, to target Vglut2 expression. This
is brought about not only because TH is endogenously
expressed in all catecholaminergic neurons thereby tar-
geting also the C1, C2 and C3 groups that have been
reported to also contain some Vglut2-expressing cells
(Stornetta et al. 2002a, b), and which therefore may con-
tribute to the behavioural phenotype, but because the TH
promoter shows a complex temporal pattern of activity that
gives rise to ‘‘promiscuous’’, but transient, activation of the
Cre recombinase also in non-catecholaminergic cells dur-
ing early development (see Illustration Fig. 8). Such pop-
ulations include both non-neuronal (e.g. germ cells and
heart cells) and neuronal cells (e.g. the dorsal and inferior
colliculus, the pontine reticulotegmental nuclei, tegmental
and parabrachial nuclei, cerebellar Purkinje cells, mam-
millary nucleus, and also scattered cells throughout the
cortex, the lateral and medial thalamus, and the striatum),
i.e. both inhibitory and excitatory populations; some of
which may coexpress Vglut2. While the normal life span of
the cKO mice, as well as the normal activational level of
the mice in the both the EPM and FST tests and when the
mice are monitored in automated locomotor chambers, are
findings suggestive of an absence of a critical role for
Vglut2 in the cardiorespiratory C1–3 neurons, the promis-
cuity of the TH promoter may present to be a greater
challenge. Indeed, we have previously shown that activa-
tion of Cre in the DRG due to transient activation of the
TH-promoter caused an itch phenotype in a subset of the
cKO mice (Lagerstro¨m et al. 2010). By selecting non-itch-
struck mice in the current study, we instead found a rather
unexpected way to take advantage of the promiscuous TH
promoter. This approach enabled, for the first time, the
targeting within all three VTA-VGLUT2 populations, i.e.
both populations (‘‘TH–Vglut2 Class 1’’ and ‘‘TH–Vglut2
Class 2’’) that express stable TH which can be detected as
protein by IHC at any stage of life as well as the population
that is characterized by absence of stable TH expression
(‘‘Vglut2-only’’), but which, as it now turned out by the
identification of the KO allele also in these cells, had
experienced TH-Cre activity during early embryo stages
(see Illustration in Fig. 8 for a summary of the Vglut2-
expressing cell groups found in the ventral midbrain at E12
and P1, respectively). In situ hybridization failed to detect a
significant difference between adult cKO and control mice,
likely due to the low number of animals used and/or the
fact that the in situ probe bound to the untargeted exons
1–3 as well as downstream targeted exons 4–6, possibly
resulting in similar binding efficiency between genotypes.
However, using semi-quantitative RT-PCR on single cell
material, as we have also done before to verify targeting of
the Vglut2 gene (Birgner et al. 2010), the KO allele was
readily detected. This TH-Cre-mediated targeting of
Vglut2 gave rise to a 97 % recombination efficiency in the
VTA/SNc area and included all three categories of popu-
lations expressing the TH-Cre-transgene, while DAT-Cre-
mediated targeting did not include the ‘‘Vglut2-only’’
population but efficiently targeted Vglut2 in DAT-Cre-
expressing cells (82 % efficiency) in the VTA/SNc area
(Birgner et al. 2010). One important caveat of the current
study concerns the extent of TH-Cre activity in the three
VTA subpopulations. Thus, while the TH-Cre-mediated
targeting was highly efficient within cells expressing the
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TH-Cre transgene of each subpopulation, we cannot rule
the existence of Vglut2-expressing cells within any of the
VTA subpopulations not expressing the TH-Cre transgene;
such cells would remain untargeted in this approach.
Behavioural phenotyping of the new TH-Cre-mediated
Vglut2 cKO mice showed the same absence of anxiety- and
depression-related phenotypes as the mice carrying a DAT-
Cre-mediated gene targeting of Vglut2, but the behavioural
profile was the ‘‘opposite’’ when it came to amphetamine-
induced psychomotor response versus hippocampus-
dependent spatial memory. The lack of alteration in
amphetamine-response was unexpected, given the strong
phenotype of the Vglut2f/f;DAT-Cre cKO mice. This finding
might be explained by the temporal (TH-Cre activity pre-
cedes that of DAT-Cre) or the spatial (selectivity) differ-
ence between the two Cre mouse lines (or both). For
example, by carrying the potential of deleting Vglut2
expression already from midgestation, temporally defined
Fig. 8 Illustration of the analysis of subpopulations in the ventral
midbrain. a Schematic drawing of an E12 mouse embryo (seen in
sagittal view) in which the ventral midbrain (VM) area, where the
dopamine (DA) neurons develop, is highlighted in red. In our analysis
(Fig. 1), we looked at the colocalization of Vglut2 mRNA with TH
immunoreactivity and found cells expressing both and either of these
genes, i.e. TH only, Vglut2 only and TH–Vglut2 together. At this
stage, DAT is not expressed, and was therefore not analysed.
b Representation of the two known phases of TH promoter activity, a
transient phase which is not specific to cells that will develop into
catecholaminergic neurons, and a stable phase which gives rise to the
stable TH expression in catecholaminergic neurons. c Schematic
drawing of the single cell selection we performed at P1 (Fig. 3) to
analyse gene expression in TH-Cre cells by RT-PCR. Coronal
midbrain slices of Ctrl-Cre-GFP and cKO-Cre-GFP mice, in which
TH-Cre activity has led to expression of the Cre-double reporter
TaumGFP thus enabling localization of these cells by GFP in
fluorescent microscope, were prepared on vibratome and the entire
GFP-positive ventral area [encompassing the A10 area (the rostral
linear nucleus of the raphe´ nuclei (RLi); paranigral nucleus (PN);
interfascicular nucleus (IF); medial parabrachial pigmented nucleus
(PbP)] together with the lateral VTA and substantia nigra pars
compacta (SNc), but not substantia nigra pars compacta (SNr) was
dissected and triturated into single cell solution from which single
GFP-positive cells were picked. d The subsequent RT-PCR analysis
using Vglut2 primers (designed to recognize mRNA both from the
wildtype and knockout in the same reaction), DAT primers and TH
primers led us to conclude that TH-Cre is active in several
populations of cells in the GFP-positive dissected area of the ventral
midbrain. Based on ours (Fig. 2) and previous studies that have
shown that, in the adult, Vglut2 is most highly expressed in the A10
nuclei and not in the lateral VTA and SNc, and our observation of
TH-Cre activity (detected as b-galacosidase in Fig. 3) suggest that the
Vglut2 mRNA we detect is derived from the A10 nuclei. We cannot
rule out that the Vglut2 we observe is derived from the lateral
structures (shadowed in grey) that were also dissected, although this
seems less likely. In summary, we found single GFP-positive cells
expressing the combination of TH, Vglut2 and DAT as illustrated by
the green dots in the figure: TH only; TH and DAT; TH and DAT and
Vglut2; TH and Vglut2 but no DAT; Vglut2 only. Cells showing TH
and DAT and Vglut2 have previously been termed ‘‘TH–Vglut2 Class
1’’ and cells showing TH and Vglut2 but no DAT have been termed
‘‘TH–Vglut2 Class 2’’, a terminology we adapted and refer to in the
current study. All literature referred to is listed in text
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developmental compensations may take place in the
Vglut2f/f;TH-Cre mice that will no longer be possible upon
targeting in the Vglut2f/f;DAT-Cre mice, which occurs several
days later. The spatially broader targeting of the TH-Cre
over the DAT-Cre, the latter of which occurs only in
subsets of DA cells and not at all in Vglut2-only cells, may
also contribute to the difference in reward-related respon-
ses, although mechanisms remain to be established.
Another important factor that has to be taken into account
is the difference in genetic backgrounds of the TH-Cre
(pure C57/Bl6 J background) and DAT-Cre [mixed
C57BL/6 J-SV129 background (Birgner et al. 2010)] mice
which, when bred to the Vglut2f/f mice (mixed C57BL/6 J-
SV129 background), give rise to offspring of which the
Vglut2f/f;TH-Cre mice will contain a higher level of C57/
Bl6 J than the Vglut2f/f;DAT-Cre mice. Thus, both selectiv-
ity and genetic background might contribute to the
observed differences in reward-related response between
the Vglut2f/f;TH-Cre mice and Vglut2f/f;DAT-Cre mice.
A deeper understanding of the observed complex hip-
pocampal phenotype will require additional approaches,
but will be discussed briefly here. Taken together, three
independent results point towards a hippocampus-related
phenotype in the TH-Cre-mediated cKO mice; the slower
acquisition and the accentuated error rate in the radial arm
maze, a spatial memory test designed to assay hippocam-
pus function (Meck et al. 1984); the significantly lower DA
tissue levels observed by electrochemical detection in
homogenates prepared from the hippocampus (while no
other region containing either DA cell bodies or projection
terminals showed similar alterations); and the increased
sensitivity to the ionotropic glutamate receptor agonist
kainate, leading to seizure-like activity in slice preparations
obtained from cKO brains. In recent studies, it was shown
in rats that severing of the signalling from the VTA to the
hippocampus via the local administration of lidocaine
(Mahmoodi et al. 2011) or baclofen (Martig and Mizumori
2011), resulted in a decreased performance in memory
tests. Neither study showed motivational or movement
disruptions, but an increase in errors and an elevated
number of trials required to reach the acquisition criterion
in memory tasks (Mahmoodi et al. 2011; Martig and
Mizumori 2011). It could therefore be proposed that the
memory deficits seen in our cKO mice may be caused by
the disruption of the DA signalling between the VTA and
hippocampus. Further, in a previous study, 6-hydroxy-
dopamine lesioning of the VTA in rats resulted in the loss
of approximately 50 % of DA neurons leading to a 74 %
reduction in DA levels in the hippocampus as well as an
83 % loss in the frontal cortex (Wisman et al. 2008). The
loss of DA was associated with a poorer reference memory
performance, with repeated trials required for the rats to
acquire the task (Wisman et al. 2008). These findings
highlight the important role of the VTA DA system in
learning and consolidation of memory. Importantly, our
observation of a decreased capability of the cKO mice
during the acquisition phase in the radial arm maze, and the
observations we make in the seizure-prone slice prepara-
tion could also be due to a loss of glutamatergic signalling,
by the targeting of ‘‘Vglut2-only’’ cells and the glutama-
tergic, instead of the dopaminergic, component of the
glutamate/DA cophenotypic cells. Electrical stimulation of
the VTA has previously been shown to elicit theta oscil-
lations, important for long-range synchronization of neu-
ronal activity, in the hippocampus (Orzeł-Gryglewska et al.
2012). Therefore, disruption of glutamatergic signalling
originating from the VTA can lead to reduced activity in
the hippocampal area. Known effects of activity depriva-
tion in the hippocampus are downregulation of GABAA
receptors (Kilman et al. 2002) and reduction of GABA
immunoreactivity, as shown in neocortical and hippocam-
pal culture neurons (Marty et al. 1997). Maintenance of
homeostasis is likely driven by a similar mechanism in the
hippocampus of cKO mice. This would, as a consequence,
lead to less activation of the hippocampal circuits through
the VTA and an adaption of the circuitry that might already
start during embryonal development. Since projections
from the VTA are severed in hippocampal slice prepara-
tions, the remaining circuit is solely dependent on inhibi-
tory and excitatory connections within the hippocampus.
As a putative result of a compensatory downregulation of
inhibitory components in the cKO mice upon the depri-
vation of VTA-derived activity, isolated hippocampal
could exhibit a general overexcitation. In the presence of
100 nM kainate, a possible imbalance in the excitation/
inhibition ratio could therefore lead to the generation of
epileptiform discharges observed in the cKO mice, while
control mice show normal gamma oscillations. Notably,
given the promiscuous nature of the TH promoter as dis-
cussed above, it is conceivable that the hippocampus-
related effects are independent of any alterations occurring
in Vglut2 expression in the VTA area, but are derived from
alterations in Vglut2 expression elsewhere. A broader range
of genetic tools for ascertaining more selective gene tar-
geting events, both spatially and temporally, should prove
helpful in resolving the functional correlation between
glutamate/dopamine transmission from the VTA and the
herein described hippocampus-related phenotypes.
In summary, using a TH-Cre knock-in strategy which
gives rise to Cre activity both in stable TH-expressing
neurons and in cells that only transiently express TH during
early development, we found a way to target Vglut2 gene
expression within all three VTA-VGLUT2 populations
identified in the medial aspects of the A10 area. Both the
unexpected absence of altered psychostimulant-induced
behavioural activation and the identification of the strong
2188 Brain Struct Funct (2015) 220:2171–2190
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deficiency in hippocampus function require further inves-
tigation, not least due to the promiscuity of the TH-Cre
transgene which is expressed in several non-neuronal and
neuronal populations in addition to the VTA. Today, most
studies, even those using optogenetics to control neural
activity, rely on DAT-Cre or TH-Cre for targeting of DA
cells. With the accelerating gain of knowledge of various
subpopulations within the A10 area, it is becoming
increasingly evident that the field would benefit from a
broader selection of genetic tools to enable further char-
acterization of the physiological roles of these different
neuronal groups.
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